- Shopping Bag ( 0 items )
The results of what one psychopharmacologist describes as a "giant, uncontrolled experiment" are just starting to trickle in. Barnett shows that a lack of ready answers and guidance has often proven extremely difficult for these young people as they transition from childhood to adolescence and now to adulthood. With its in-depth accounts of individual experiences combined with sociological and scientific context, Dosed provides a much-needed road map for patients, friends, parents, and those in the helping professions trying to navigate the complicated terrain of growing up on meds.
From the Introduction
I fall hard for coming-of-age stories, and my list of favorite books and movies contains many in this genre, from Pride and Prejudice to The Catcher in the Rye. The movie Garden State, which starred Zach Braff and Natalie Portman, also struck a chord with me when it came out in 2004. It dramatizes a few days in the life of Andrew Largeman, a twenty-six-year-old struggling actor in Los Angeles who returns to his native New Jersey for his mother’s funeral. Andrew is nothing if not alienated: he feels disconnected from celebrity-studded Hollywood as well as from his old hometown, which he hasn’t visited since leaving for boarding school nearly a decade earlier. For the first time in sixteen years, Andrew has stopped taking the psychotropic medications his psychiatrist father prescribed after ten-year-old Andrew caused an accident that rendered his mother a paraplegic. Like the illegal drugs his high school buddies take, Andrew’s meds serve as a metaphor for the feelings of inadequacy, disappointment, and rootlessness endemic to my generation of twenty-somethings. Judging from the film’s cult-hit success, its target audience of my peers apparently found the metaphor apt. When Andrew falls in love with a quirky, vibrant girl he meets in a doctor’s waiting room, she shows him how to reengage with his feelings—and the world. Presumably, he leaves the medications behind.
For several years, Garden State remained my favorite movie about my generation. It spoke to me as a young person growing up in turn-ofthe-millennium America—though not as a young medicated person. In fact, I completely forgot psychiatric drugs were even mentioned. Funny, because I myself have been taking medication since high school, and Garden State is one of just a couple of films I know of to allude to the psychological impact of growing up taking psychotropic drugs. But although it touches on this important phenomenon, the film never really examines its underlying assumptions that medications numbed Andrew’s pain and guilt, and that getting off them allows him once again to experience the agony and ecstasy of life.
For the first time in history, millions of young Americans are in a position not unlike Andrew’s: they have grown up taking psychotropic medications that have shaped their experiences and relationships, their emotions and personalities, and, perhaps most fundamentally, their very sense of themselves. In Listening to Prozac, psychiatrist Peter Kramer’s best-selling meditation on the drug’s wide-ranging impact on personality, Kramer said that “medication rewrites history.” He was referring to the way people interpret their personal histories once they have begun medication; what they thought was set in stone was now open to reevaluation. What, then, is medication’s effect on young people, for whom there is much less history to rewrite? Kramer published his book in 1993, at a time of feverish—and, I think, somewhat excessive—excitement about Prozac and the other selective serotonin reuptake inhibitor antidepressants, or SSRIs, that quickly followed on its heels and were heralded as revolutionary treatments for a variety of psychiatric problems. For most people, I suspect, medications are perhaps less like a total rewriting of the past than a palimpsest. They reshape some of one’s interpretations about oneself and one’s life but allow traces of experience and markers of identity to remain. The earlier in life the drugs are begun, the fewer and fainter those traces and markers are likely to be. All told, the psychopharmacological revolution of the last quarter century has had a vast impact on the lives and outlook of my generation—the first generation to grow up taking psychotropic medications. It is therefore vital for us to look at how medication has changed what it feels like to grow up and to become an adult.
• • •
Our society is not used to thinking about the fact that so many young people have already spent their formative years on pharmaceutical treatment for mental illness. Rather, we focus on the here-and-now, wringing our hands about “overmedicated kids.” We debate whether doctors, parents, and teachers rely too heavily on meds to pacify or normalize or manage the ordinary trials of childhood and adolescence. Often, the debate has a socioeconomic dimension that attributes overmedication either to the striving middle and upper-middle classes, or to the social mechanisms used to control poor children and foster children. We question the effectiveness and safety of treating our youth with these drugs, most of which have not been tested extensively in children and are not government-approved for people under eighteen. We worry about what the drugs will do to developing brains and bodies, both in the short and long term. The omnipresent subtext to all this: what does the widespread “drugging” of minors say about our society and our values? Certainly, these questions are worth debating—even agonizing over. But they ought not to constitute the be-all and end-all of our society’s conversation about young people and psychiatric drugs, particularly with millions of medicated teens transitioning into adulthood. Too much of the discussion occurs in the abstract, and drugs too easily become a metaphor, as in Garden State, for a variety of modern society’s perceived ills: the fast pace of life and the breakdown of close social and family ties; a heavy emphasis on particular kinds of academic and professional achievement; a growing intolerance and impatience with discomfort of any sort. Far too rarely, though, do we consult young people themselves. How do they feel about taking medication? How do they think it has shaped their attitudes, their sense of themselves, their academic and career paths, their lives? How do they envision medication affecting their futures?
Focusing on people who needed therapeutic intervention early in life and who continued to use medication for an extended period of time can help us get past the are-they-or-aren’t-they nature of the “overmedicated kids” debate. By assessing what medication has actually meant for my peers, I hope to get at something more intimate and more complex than either the psychotropic true believers or the total skeptics allow themselves to consider. “A prescription becomes an event that generates fantasies, wishes, concerns, and meaning,” write the social scientists Tally Moses and Stuart Kirk in an analysis of young people’s experiences of psychotropic meds. “It structures one’s own expectations and those of others in ways that are not necessarily intended or foreseen.”
As Moses and Kirk suggest, the experience of taking psychotropic drugs is more than just popping a pill, and these drugs often become a part of the self in ways children and teenagers could not have imagined when they swallowed their first dose. Now that the first generation of medicated kids is entering adulthood, we have an invaluable opportunity to hear about their experiences with psychotropic drugs, and their assessment of those experiences. In addition to looking at the family, medical, and educational circumstances in which drugs are prescribed and taken, that is what this book sets out to do.
My cohort lives with some powerful contradictions. On the one hand, we have grown up with the idea that prolonged sadness, attention problems, obsessions and compulsions, and even shyness are brain diseases that can—and ought—to be treated with medication, just as a bodily disease like diabetes ought to be treated with insulin. The 1990s, sometimes called “the Decade of the Brain,” encompassed a period of unprecedented growth in understanding how the brain works, which generated enormous enthusiasm about the prospects for discovering the underlying mechanisms behind mental illness, enthusiasm that many say was overwrought and premature. Direct-to-consumer pharmaceutical advertising on TV, which the U.S. Food and Drug Administration authorized in 1997, has allowed drug companies to define the public’s understanding of mental illness and psychiatric medications—and this is especially true, I think, for young people who knew no other paradigm. Even as we grew up, though, immersed in the idea of an “imbalance” of particular brain chemicals—an outdated theory that has not held up to the science—we have inherited the American ideal of self-sufficiency, of solving one’s problems through one’s own resourcefulness. As we’ve sought to forge our identities, we have often struggled to reconcile the two.
• • •
It took me a while to conceive of my medicated peers as a coherent group, much less one deserving of a book-length study. Until recently, I would not even have included myself in the category of people whose formative years were shaped by psychotropic drugs, let alone shaped in any profound way. When I began taking Prozac at age seventeen, I didn’t spend a lot of time contemplating whether I’d lose some essential aspect of my identity, and I certainly didn’t consider myself a part of any larger societal phenomenon. I was only vaguely aware that various drugs like Prozac had become available in the late 1980s and through the 1990s, and that they had helped a lot of people.
Before taking Prozac, I had spent two years in therapy with first one therapist and then another. To a depressed adolescent, two years feels as though it’s an eon. I thought it was time to give medication a try. I was far less concerned with the implications of taking a psychiatric drug than I was with banishing the exhausting and oppressive symptoms of my pervasive unhappiness: the apathy and hopelessness, the irritability and boredom, the pessimism and incessant self-criticism. For several years these symptoms had seemed to colonize my entire being, and when they abated after a couple of months of Prozac, I credited the medication. I figured a “chemical imbalance” must be to blame, and skipped the philosophizing. Even when Prozac seemed to stop working five years later and I began, in desperation, trying a battery of other antidepressants and antianxiety drugs, I still basically swallowed the pills and left it at that. The drugs only mattered to me insofar as they treated, or failed to treat, my symptoms.
Then, shortly before my twenty-fifth birthday, seven years into my life on medication, I read a column in the New York Times about a young woman in her early thirties who had been taking antidepressants almost continuously since she was fourteen. Richard A. Friedman, the young woman’s psychiatrist and a frequent contributor to the science section of the Times, noted that the patient “credited the medication with saving her life.” But, he wrote, she had also begun to struggle with the “equally fundamental question” of how the drugs had shaped her psychological development and, ultimately, her identity. Noting the huge increase in the number of youths taking antidepressants and other psychotropic drugs, Friedman postulated that his patient was just one of innumerable people entering adulthood with such concerns. With little scientific data on how drugs affect the developing body and mind, he added, these were problems for which few answers were forthcoming.
I was intrigued. Since I didn’t relate to the woman’s doubts and anxieties, I wondered whether starting medication at a younger age than I did, at a more vulnerable and unstable period in her emotional development, had contributed to her discomfort. I can’t say the article suddenly prompted me to start questioning who I’d be had I never taken Prozac, but it did make me intensely curious about my peers. Who are these people, I wondered, and why are they so ambivalent about their medication? I didn’t know anyone who fit the bill, so I began looking.
I talked to friends of friends, current college students and recent graduates I met through campus mental health groups, and I joined online forums for mood and behavior disorders, both those devoted specifically to psychotropic medication and more general sites where people post their medical data and histories, such as Patients-Like-Me. Since I identified myself as a journalist, I suspect most people didn’t want to talk to me at all, fearing public disclosure of a private, online identity. Others shared my initial, uncomplicated assessment: the medication worked, therefore, they must have had a biochemical malfunction in their brains, as much a disease as diabetes and no more profound.
The more stories I heard, though, the more it seemed that even people who believed, on balance, that the drugs helped them—somehow made them more stable, motivated, focused, reliable, or upbeat—still entertained plenty of ambivalence about issues such as what side effects the medications caused and how to understand their identity while taking a drug that affected their mood, behavior, and maybe even their entire personality. Some harbored these suspicions from the get-go; others developed them over time. “At first, I thought, ‘Oh, okay, yeah, that’ll make me feel better,’ ” one young woman from outside Boston told me of her experience beginning antidepressants at age eleven. “And then it entered my consciousness more that it was something more serious . . . that had stronger effects on my being.”
Chapter 1 Difficult Kids
Chapter 2 Playing a Role: The Medicated Kid
Chapter 3 School Interventions
Chapter 4 Early Rebellions
Chapter 5 Something New?
Chapter 6 Breakdowns
Chapter 7 Side Effects
Chapter 8 Complicating Factors
Chapter 9 Reassessments
Posted April 15, 2012
I attended a book reading at Book Court and purchased this book. I am not in the mental health profession and have no prior association with the writer.
I recommend this book highly. I have personal experience with this subject: two now grown-up kids using the class of drugs described in this book, one childhood friend who died of side-effects of anti-psychotic drugs, and I also swallow a Zoloft daily. If I had read this book before my kids started medication and therapy, the kids would have benefited, and I would have got a lot more out of my multi-hundred thousand dollar investment.
What did I like about this book? First, I admire the journalistic professionalism of the writer. She points out that too much of the discussion of this topic occurs in the abstract, and that drugs too easily become a metaphor for something else. The subject tends to be discussed in a generalizing and polemical way. The writer has avoided this completely. Her observations are grounded on a mastery of the professional literature, and from the personal experience of the writer and her interview subjects. It is a nuanced, well-rounded treatment of the subject, and the work offers some good practical suggestions to parents and professionals.
I hope people will read the book, but here are just some of the writer's insights that I found interesting and useful:
- She talks about how important it is to explain the disorder and the treatment to the child, and how difficult it is to encourage children to take ownership of their own treatment. If this is not done correctly, the result is non-compliance or chaos (I've seen it).
- At the same time that children know how to manipulate adults and game the system, they are very secretive, and often legitimately feel that therapy is an invasion of their privacy. (One of my children became an expert at lying to therapists).
- The conditions of children change rapidly and it is difficult to arrive at one diagnosis. Since scientists don't really understand why some of these medicines work or don't work, the treatment has to be closely monitored and adjustments can be necessary. Let's admit it, it's just a process of trial and error. (One of my sons reached age 20 and his psychiatrist still couldn't pin down what his affliction was at all. It might be depression, it might be ADD, it might be anything... you get the idea).
From a father and bill-payer's standpoint the writer also dances around another subject that is important. People, including professionals, do what they are incented to do. This is as true of the mental health field as it is for Wall Street. In this case, pharmaceutical companies, attorneys, psychiatrists and various flavors of therapists all make money delivering services "for the sake of the children," therefore ANYTHING they do is justified, so long as the child does not commit suicide without a signed waiver. Except for all the attorneys except one, I think that the professionals who treated my children were good-intentioned for the most part. However, in my experience there was no accountability in terms of demonstrating that the services had any positive impact. This is especially true of endless talk therapy, where the child can hone their skills in killing time and lying, without the therapist ever feeling any compulsion to report back that the treatment is not working. This is my opinion, not the writer's.
Buy this book!
1 out of 1 people found this review helpful.Was this review helpful? Yes NoThank you for your feedback. Report this reviewThank you, this review has been flagged.
Posted November 25, 2012
Posted November 25, 2012
Posted November 24, 2012
Posted November 24, 2012
Posted November 24, 2012
Posted November 25, 2012